Stay updated on BIO89-100 Multiple Dose in NASH Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.

Latest updates to the BIO89-100 Multiple Dose in NASH Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol (v2.15.0) and includes the name of the study collaborator, ProSciento, Inc. Additionally, the masking description has been retained, indicating that Part 1 was blinded and Part 2 was open label.SummaryDifference15%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to BIO89-100 Multiple Dose in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.